Ebenbichler, Christoph http://orcid.org/0000-0001-5025-7929
Drexel, Heinz http://orcid.org/0000-0002-4677-9756
Hanusch, Ursula
Toplak, Hermann http://orcid.org/0000-0002-7513-5167
Dhalwani, Nafeesa N. http://orcid.org/0000-0001-7368-3306
Bridges, Ian http://orcid.org/0000-0002-3317-3528
Hoelzl, Robert http://orcid.org/0000-0001-7636-8002
Hemetsberger, Margit http://orcid.org/0000-0003-1877-6838
Ray, Kausik K. http://orcid.org/0000-0003-0508-0954
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
Received: 1 March 2023
Accepted: 16 June 2023
First Online: 31 July 2023
Declarations
:
: C. Ebenbichler received research grants from NovoNordisk, Sanofi and AAS, consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim, Novartis and Sanofi, and gave lectures for Amgen, Novartis and Sanofi. H. Toplak has received research grants from Amgen, Sanofi, Novartis, MSD and Regeneron, consulting fees from Amgen, Sanofi, Novartis, Mylan, Takeda, Servier and AstraZeneca, and has lectured for Amgen, Sanofi, NovoNordisk, Mylan, AstraZeneca and Pfizer. M. Hemetsberger received consulting fees from Amgen and owns Amgen shares. K.K. Ray reports grants from Amgen during the conduct of the study; personal fees from AbbVie, Aegerion, Akcea, Algorithm, AstraZeneca, Bayer, Boehringer Ingelheim, Cerenis, Cipla, Dr Reddys, Esperion, Kowa, Lilly, Novartis, Silence Therapeutics, Takeda, The Medicines Company, and Zuelling Pharma; and grants and personal fees from Amgen, Daiichi Sankyo, MSD, Sanofi–Regeneron, and Pfizer, outside the submitted work. I. Bridges, N.N. Dhalwani and R. Hoelzl are employees of Amgen and own Amgen shares. H. Drexel and U. Hanusch declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards and was consistent with the International Council for Harmonization. In Austria, the study protocol and the amendment were reviewed by the ethics committee of Graz Medical University. Informed consent was obtained from all individual participants included in the study.